Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Reexamination Certificate
2006-10-03
2006-10-03
Weber, Jon (Department: 1653)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
C530S350000, C514S012200
Reexamination Certificate
active
07115707
ABSTRACT:
This invention relates to novel pharmaceutical penetration compositions capable of facilitating penetration of at least one effector across biological barriers. The invention also relates to methods of treating or preventing diseases by administering penetration compositions to affected subjects.
REFERENCES:
patent: 4179337 (1979-12-01), Davis et al.
patent: 4873316 (1989-10-01), Meade et al.
patent: 2003/0060438 (2003-03-01), Henry et al.
patent: 2004/0176476 (2004-09-01), Gyurik
patent: WO 96/05858 (1996-02-01), None
patent: WO 03/066859 (2003-08-01), None
Henry et al., U.S. Appl. No. 60/226,086, filed Aug. 18, 2000.
Gyurik, U.S. Appl. No. 60/300,293, filed Jun. 22, 2001.
Ho et al., Influence of pluronic F-68 on dissolution and bioavailability characteristics of multiple-layer pellets of nifedipine for controlled release delivery, Journal of controlled release, vol. 68, issue 3, Sep. 3, 2000, pp. 433-440.
Written Opinion for PCT/IB03/00968, mailing date: Jul. 8, 2004.
Amann, et al.,Gene, 69(2):301-315 (1988).
Armstrong, W.M.,Physiol. Gastrointest. Tract, 2ndEd., Johnson, ed., Raven Press, New York, 2:1251-1265 (1987).
Baldari, et al.,EMBO J., 6(1):229-234 (1987).
Banerji, et al.,Cell, 729-740 (1983).
Bernkop-Schnurch, et al.,J. Control. Release, 52:1-16 (1998).
Byrne, et al.,Proc. Natl. Acad. Sci. USA, 86:5473-5477 (1989).
Calame, et al.,Adv. Immunol., 43:235-275 (1988).
Camper, et al.,Genes Dev., 3(4):537-546 (1989).
Edlund, et al.,Science, 230:912-916 (1985).
Fox,Curr. Opin. Pharmacol., 2:338-344 (2002).
Gottesman,Gene Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, Calif., pp. 119-128 (1990).
Gumbiner,Am. J. Physiol., 253(6):C749-C758 (1987).
Inoue, et al.,Inflamm. Res., 45(7):316-323 (1996).
Jackson, L.R.,Physiol. Gastrointest. Tract, 2ndEd., Johnson, ed., Raven Press, New York, 2:1597-1621 (1987).
Kaufman, et al., EMBO J., 6:187-195 (1987).
Kessel, et al.,Science, 249:374-379 (1990).
Kurjan, et al.,Cell, 30(3):933-943 (1982).
Luckow, et al.,Virology, 170(1):31-39 (1989).
Madara,J. Clin. Invest., 83(4):1089-1094 (1989).
Merrifield, R.B.,J. Am. Chem. Soc., 85:2151-2154 (1963).
O'Shaughnessy, et al.,Euro. J. Pharm., 236(2):319-321 (1993).
Pinkert, et al.,Genes Dev., 1(3):268-277 (1987).
Queen, et al.,Cell, 33:741-748 (1983).
Schilfgaarde, et al.,Infect. Immun., 68(8):4616-4623 (2000).
Schultz, et al.,Gene, 54(1):113-123 (1987).
Seed B.,Nature, 329:840-842 (1987).
Smith, et al.,Mol. Cell. Biol., 3(12):2156-2165 (1983).
Studier, et al.,Gene Expression Technology: Methods in Enzymology, Academic Press, San Diego, Calif., 185:60-89 (1990).
Wada, et al.,Nucl. Acids Res., 20:2111-2118 (1992).
Weintraub, et al., “Anti-sense RNA as a Molecular Tool for Genetic Analysis”,Reviews-Trends in Genetics, 1:22-25 (1985).
Winoto, et al.,EMBO J., 8(3):729-733 (1989).
Yowell, et al.,Cancer Treat. Rev., 28(Suppl. A):3-6 (2002).
Ben-Sasson Shmuel A.
Cohen Einat
Chiasma, Inc.
Elrifi, Esq. Ivor R.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
Mondesi Robert B.
Stock, Esq. Christina K.
LandOfFree
Amino acid sequences capable of facilitating penetration... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino acid sequences capable of facilitating penetration..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino acid sequences capable of facilitating penetration... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3696957